A238200 logo

BIFIDO Co., Ltd. Stock Price

KOSDAQ:A238200 Community·₩21.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

A238200 Share Price Performance

₩2,630.00
-925.00 (-26.02%)
₩2,630.00
-925.00 (-26.02%)
Price ₩2,630.00

A238200 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with very low risk.

2 Risks
0 Rewards

BIFIDO Co., Ltd. Key Details

₩17.2b

Revenue

₩10.9b

Cost of Revenue

₩6.3b

Gross Profit

₩8.2b

Other Expenses

-₩1.9b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-230.53
36.44%
-10.95%
22.5%
View Full Analysis

About A238200

Founded
1999
Employees
83
CEO
Myeongsoo Park
WebsiteView website
www.bifido.com

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.

Recent A238200 News & Updates

Analysis Article Oct 17

Some Confidence Is Lacking In BIFIDO Co., Ltd.'s (KOSDAQ:238200) P/S

BIFIDO Co., Ltd.'s ( KOSDAQ:238200 ) price-to-sales (or "P/S") ratio of 1.7x may not look like an appealing investment...

Recent updates

No updates